<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02734953</url>
  </required_header>
  <id_info>
    <org_study_id>RC6167</org_study_id>
    <nct_id>NCT02734953</nct_id>
  </id_info>
  <brief_title>Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH</brief_title>
  <official_title>Effects of iNO on Invasively Derived Pulmonary Vascular Parameters in Patients With Pulmonary Arterial Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary hypertension is characterized by an increase in the pressures in the blood supply
      to the lungs greater than a mean pressure of 25mmHg and a concomitant increase in overall
      pulmonary vascular resistance (PVR). In patients who have remodeling of their pulmonary
      vasculature, PVR will increase with exercise instead of decreasing as it would in normal
      patients. Based on published evidence, the investigators intend to investigate the effects of
      inhaled nitric oxide (iNO) on patients undergoing standard exercise techniques who have
      separately and previously had an implanted pulmonary artery monitoring device (CardioMems by
      St Jude Medical, Inc.) placed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Ambulatory 6 Minute Walk Distance (6MWD) Pulmonary Artery (PA) Pressures (Systolic, Diastolic, Mean) Between the Post-intervention (iNO+) and Pre-intervention (iNO-) Condition as Measured by the CardioMems Device</measure>
    <time_frame>2 hours</time_frame>
    <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in CardioMems Cardiac Output</measure>
    <time_frame>2 hours</time_frame>
    <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 6 Minute Walk Distance (6MWD)</measure>
    <time_frame>2 hours</time_frame>
    <description>Difference (in distance walked between 2 set points over 6 minutes) at baseline (t=0) to post-intervention (t=2h).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in O2 Saturations</measure>
    <time_frame>2 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Modified Borg Dyspnea Scale</measure>
    <time_frame>2 hours</time_frame>
    <description>The Modified Borg Dyspnea scale measures patient's subjective analysis of dyspnea from 0 (&quot;nothing at all&quot;) to 10 (&quot;maximal&quot;) during the 6MWD test with the highest value recorded and difference calculated between baseline (t=0) and post-intervention (t=2h).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in O2 Requirements</measure>
    <time_frame>2 hours</time_frame>
    <description>Number of patients that required more or less oxygen by nasal prongs during the course of the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Mean Arterial Pressure</measure>
    <time_frame>2 hours</time_frame>
    <description>Difference between baseline (t=0) and post-intervention (t=2h).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Heart Rate</measure>
    <time_frame>2 hours</time_frame>
    <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Rate Pressure Product</measure>
    <time_frame>2 hours</time_frame>
    <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Right Ventricular (RV) Power</measure>
    <time_frame>2 hours</time_frame>
    <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Stroke Volume</measure>
    <time_frame>2 hours</time_frame>
    <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in RV Stroke Work Index</measure>
    <time_frame>2 hours</time_frame>
    <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitric Oxide</intervention_name>
    <description>Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>iNOPulse DS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females age 18 to 80 years with a diagnosis of pulmonary arterial
             hypertension (WHO Group I pulmonary hypertension).

          -  Must be able to read and understand English and consent for themselves

          -  Previously implanted CardioMems continuous PA pressure

          -  Ambulatory and able to complete 6MWD test.

        Exclusion Criteria:

          -  Pregnant or lactating females; negative pregnancy test as confirmed by evaluation of
             data from pre-enrolled Risk Evaluation and Mitigation Strategies (REMS) program.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raymond L Benza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>West Penn Allegheny Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Frantz RP, Benza RL, Kjellström B, Bourge RC, Barst RJ, Bennett TD, McGoon MD. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension. J Heart Lung Transplant. 2008 Jul;27(7):780-8. doi: 10.1016/j.healun.2008.04.009. Epub 2008 Jun 2.</citation>
    <PMID>18582809</PMID>
  </reference>
  <reference>
    <citation>Hasuda T, Satoh T, Shimouchi A, Sakamaki F, Kyotani S, Matsumoto T, Goto Y, Nakanishi N. Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension. Circulation. 2000 May 2;101(17):2066-70.</citation>
    <PMID>10790348</PMID>
  </reference>
  <reference>
    <citation>Kjellström B, Frantz RP, Benza RL, Bennett T, Bourge RC, McGoon MD. Hemodynamic ranges during daily activities and exercise testing in patients with pulmonary arterial hypertension. J Card Fail. 2014 Jul;20(7):485-91. doi: 10.1016/j.cardfail.2014.04.019. Epub 2014 May 9.</citation>
    <PMID>24816520</PMID>
  </reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>March 26, 2016</study_first_submitted>
  <study_first_submitted_qc>April 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <results_first_submitted>July 27, 2018</results_first_submitted>
  <results_first_submitted_qc>August 24, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">September 24, 2018</results_first_posted>
  <last_update_submitted>August 24, 2018</last_update_submitted>
  <last_update_submitted_qc>August 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)</investigator_affiliation>
    <investigator_full_name>Raymond Benza</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <keyword>Inhaled nitric oxide</keyword>
  <keyword>Exercise</keyword>
  <keyword>6 minute walk test</keyword>
  <keyword>CardioMems</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>With sponsor to provide statistical analysis</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment period: June 1-25, 2016 Recruitment Location: medical clinic</recruitment_details>
      <pre_assignment_details>All enrolled participants were included,</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Intervention</title>
          <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intervention</title>
          <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Difference in Ambulatory 6 Minute Walk Distance (6MWD) Pulmonary Artery (PA) Pressures (Systolic, Diastolic, Mean) Between the Post-intervention (iNO+) and Pre-intervention (iNO-) Condition as Measured by the CardioMems Device</title>
        <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Ambulatory 6 Minute Walk Distance (6MWD) Pulmonary Artery (PA) Pressures (Systolic, Diastolic, Mean) Between the Post-intervention (iNO+) and Pre-intervention (iNO-) Condition as Measured by the CardioMems Device</title>
          <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PA pressure systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.86" lower_limit="-22.96" upper_limit="9.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PA pressure diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.40" lower_limit="-10.54" upper_limit="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PA pressure mean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.45" lower_limit="-14.97" upper_limit="9.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in CardioMems Cardiac Output</title>
        <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in CardioMems Cardiac Output</title>
          <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" lower_limit="-1.34" upper_limit="5.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in 6 Minute Walk Distance (6MWD)</title>
        <description>Difference (in distance walked between 2 set points over 6 minutes) at baseline (t=0) to post-intervention (t=2h).</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in 6 Minute Walk Distance (6MWD)</title>
          <description>Difference (in distance walked between 2 set points over 6 minutes) at baseline (t=0) to post-intervention (t=2h).</description>
          <units>m</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.6" lower_limit="-16" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in O2 Saturations</title>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in O2 Saturations</title>
          <units>% O2 Sat</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1" lower_limit="-3" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Modified Borg Dyspnea Scale</title>
        <description>The Modified Borg Dyspnea scale measures patient's subjective analysis of dyspnea from 0 (&quot;nothing at all&quot;) to 10 (&quot;maximal&quot;) during the 6MWD test with the highest value recorded and difference calculated between baseline (t=0) and post-intervention (t=2h).</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Modified Borg Dyspnea Scale</title>
          <description>The Modified Borg Dyspnea scale measures patient's subjective analysis of dyspnea from 0 (&quot;nothing at all&quot;) to 10 (&quot;maximal&quot;) during the 6MWD test with the highest value recorded and difference calculated between baseline (t=0) and post-intervention (t=2h).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" lower_limit="-2" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in O2 Requirements</title>
        <description>Number of patients that required more or less oxygen by nasal prongs during the course of the study.</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in O2 Requirements</title>
          <description>Number of patients that required more or less oxygen by nasal prongs during the course of the study.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Mean Arterial Pressure</title>
        <description>Difference between baseline (t=0) and post-intervention (t=2h).</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Mean Arterial Pressure</title>
          <description>Difference between baseline (t=0) and post-intervention (t=2h).</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7" lower_limit="-17" upper_limit="-1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Heart Rate</title>
        <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Heart Rate</title>
          <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
          <units>bpm</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="-25" upper_limit="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Rate Pressure Product</title>
        <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Rate Pressure Product</title>
          <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
          <units>mmHg*beat/min</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="316" lower_limit="-3490" upper_limit="8900"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Right Ventricular (RV) Power</title>
        <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Right Ventricular (RV) Power</title>
          <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
          <units>J/s</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00685" lower_limit="-0.150" upper_limit="0.241"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Stroke Volume</title>
        <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Stroke Volume</title>
          <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.97" lower_limit="-20.8" upper_limit="28.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in RV Stroke Work Index</title>
        <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
          </group>
        </group_list>
        <measure>
          <title>Change in RV Stroke Work Index</title>
          <description>Difference between baseline (t=0) and post-intervention (t=2h)</description>
          <units>g*m/m2</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.80" lower_limit="-11.6" upper_limit="1.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Intervention</title>
          <description>Determination of non-invasive pulmonary pressures by CardioMems device interrogation pre- and post-administration of inhaled nitric oxide at 0.075 mg/kg IBW/hr
Nitric Oxide: Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Raymond Benza</name_or_title>
      <organization>Allegheny Health Network</organization>
      <phone>412-359-3131</phone>
      <email>raymond.benza@ahn.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

